nimodipine has been researched along with Age-Related Macular Degeneration in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riva, CE | 1 |
| Falsini, B | 1 |
| Anselmi, G | 1 |
| Gari, M | 1 |
1 other study available for nimodipine and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Clinic use of Laser Doppler Flowmetry (LDF) in the study of subfoveal choroidal circulation].
Topics: Carbon Dioxide; Choroid; Diabetic Retinopathy; Fovea Centralis; Humans; Laser-Doppler Flowmetry; Low | 2011 |